Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels

被引:23
|
作者
Askalany, AR
Yamakura, T [1 ]
Petrenko, AB
Kohno, T
Sakimura, K
Baba, H
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Anesthesiol, Niigata 9518510, Japan
[2] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan
关键词
agmatine; spermine; NMDA receptor channels; epsilon subunit; channel blocker;
D O I
10.1016/j.neures.2005.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endogenous polyamines like spermine are known to have four distinct effects on recombinant N-methyl-D-aspartate (NMDA) receptor channels: voltage-dependent inhibition, glycine-dependent Stimulation, glycine-independent stimulation and decreased affinity to the agonist (L-glutamate). These effects are highly dependent on the constituting F subunits (epsilon 1-r4) of the recombinant NMDA receptor channels. Agmatine reportedly inhibits native NMDA receptor channels in cultured hippocampal neurons. In the present investigation, the effects of agmatine on the epsilon/zeta heteromeric NMDA receptor channels expressed in Xenopus laevis oocytes were examined using the two-electrode voltage clamp method. Agmatine inhibited the four epsilon/zeta (epsilon 1/zeta 1, epsilon 2/zeta 1, epsilon 4/zeta 1 and epsilon 4/zeta 1) channels with similar sensitivity (an IC50 value of about 300 mu M at -70 mV). This effect was dependent on the membrane potential and was more pronounced at hyperpolarized membrane potentials (vottage-dependent inhibition). Agmatine did not exhibit other stimulatory (glycine-dependent and -independent effects) or inhibitory (decreased affinity to L-glutamate) effects. These properties are similar to the pharmacological profile of well-characterized NMDA receptor channel blockers like phencyclidine and ketamine. Thus, regarding the effects on the NMDA receptor channels, agmatine is not like other endogenous polyamines rather it acts as a channel blocker. (c) 2005 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:387 / 392
页数:6
相关论文
共 50 条
  • [41] The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia
    Henriksson, KG
    Sörensen, J
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (02) : 343 - +
  • [42] Deramciclane inhibits N-methyl-D-aspartate receptor function
    Kovács, I
    Szárics, É
    Skuban, N
    Kardos, J
    BRAIN RESEARCH BULLETIN, 2000, 52 (01) : 39 - 44
  • [43] Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists
    Poschenrieder, H
    Stachel, HD
    Höfner, G
    Mayer, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (04) : 391 - 400
  • [44] Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum
    Cepeda, C
    Levine, MS
    DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (01) : 1 - 18
  • [45] The N-Methyl-D-Aspartate Receptor: Memory, Madness, and More
    Ramirez, Alejandro
    Arbuckle, Melissa R.
    BIOLOGICAL PSYCHIATRY, 2017, 82 (01) : E1 - E3
  • [46] Delayed N-methyl-D-aspartate Receptor Encephalitis Relapse
    AlShimemeri, Sohaila
    Alsaeed, Meshari
    Lai, Joshua
    Uy, Christopher
    Javidan, Manouchehr
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2020, 47 (02) : 264 - 266
  • [47] N-Methyl-D-Aspartate Receptor in Human Prostate Cancer
    M. Abdul
    N. Hoosein
    The Journal of Membrane Biology, 2005, 205 : 125 - 128
  • [48] Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy
    Xu, Xing-Xing
    Luo, Jian-Hong
    NEUROSCIENCE BULLETIN, 2018, 34 (03) : 549 - 565
  • [49] N-methyl-D-aspartate receptor in human prostate cancer
    Abdul, M
    Hoosein, N
    JOURNAL OF MEMBRANE BIOLOGY, 2005, 205 (03): : 125 - 128
  • [50] The fyn art of N-methyl-D-aspartate receptor phosphorylation
    Sala, C
    Sheng, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 335 - 337